The relevance of serum ghrelin concentration to severity of acute pancreatitis

Gut and Liver

Volumn 4, Issue 2, 2010, Pages 234-240

  Lee, Se Hyung ^a   Kim, Young Don ^a   Kong, Yun Ho ^a   Han, Koon Hee ^a   Jeong, Woo Jin ^a   Lee, Sang Jin ^a   Cheon, Gab Jin ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Acute pancreatitis; Ghrelin

Indexed keywords

GHRELIN;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BLOOD SAMPLING; DISEASE SEVERITY; FEMALE; HOSPITAL DISCHARGE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; RISK FACTOR;

EID: 77953573821     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2010.4.2.234     Document Type: Article

References (25)

1. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974;139:69-81.
2. Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 1990;77:1260-1264.
3. Dominguez-Munoz JE, Carballo F, Garcia MJ, et al. Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: results of a multicentre study. Br J Surg 1991;78:1230-1234.
4. Gudgeon AM, Heath DI, Hurley P, et al. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990;335:4-8. (Pubitemid 20020419)
5. Tenner S, Fernandez-del Castillo C, Warshaw A, et al. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int J Pancreatol 1997;21:105-110. (Pubitemid 27278608)
6. Puolakkainen P, Valtonen V, Paananen A, Schroder T. C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis. Gut 1987;28:764-771. (Pubitemid 17082225)
7. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990;174:331-336. (Pubitemid 20038583)
8. Tritos NA, Kokkotou EG. The physiology and potential clinical applications of ghrelin, a novel peptide hormone. Mayo Clin Proc 2006;81:653-660.
9. Wierup N, Svensson H, Mulder H, Sundler F. The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept 2002;107:63-69. (Pubitemid 34876446)
10. Dembinski A, Warzecha Z, Ceranowicz P, et al. Ghrelin attenuates the development of acute pancreatitis in rat. J Physiol Pharmacol 2003;54:561-573. (Pubitemid 38029752)
11. Liu B, Liu X, Tang C. Change of plasma ghrelin level in acute pancreatitis. Pancreatology 2006;6:531-535. (Pubitemid 46360710)
12. Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006;101:2379-2400.
13. Triester SL, Kowdley KV. Prognostic factors in acute pancreatitis. J Clin Gastroenterol 2002;34:167-176.
14. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000;141:4255-4261.
15. Hataya Y, Akamizu T, Takaya K, et al. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 2001;86:4552. (Pubitemid 32848588)
16. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992.
17. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002;346:1623-1630. (Pubitemid 34755670)
18. Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 2006;55:327-333. (Pubitemid 43268268)
19. Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 2000;276:905-908.
20. Nagaya N, Uematsu M, Kojima M, et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001;104:1430-1435. (Pubitemid 32880158)
21. Nagaya N, Miyatake K, Uematsu M, et al. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J Clin Endocrinol Metab 2001;86:5854-5859.
22. Jaworek J. Ghrelin and melatonin in the regulation of pancreatic exocrine secretion and maintaining of integrity. J Physiol Pharmacol 2006;57 Suppl 5:83-96.
23. Leite-Moreira AF, Soares JB. Physiological, pathological and potential therapeutic roles of ghrelin. Drug Discov Today 2007;12:276-288.
24. Katergari SA, Milousis A, Pagonopoulou O, Asimakopoulos B, Nikolettos NK. Ghrelin in pathological conditions. Endocr J 2008;55:439-453.
25. Isomoto H, Ueno H, Nishi Y, et al. Circulating ghrelin levels in patients with various upper gastrointestinal diseases. Dig Dis Sci 2005;50:833-838.